Dimensional Fund Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,648
| Closed | -$124K | – | 3435 |
|
|
2023
Q4 | $124K | Sell |
4,648
-2,366
| -34% | -$63.3K | ﹤0.01% | 3257 |
|
|
2023
Q3 | $424K | Sell |
7,014
-4,182
| -37% | -$253K | ﹤0.01% | 3075 |
|
|
2023
Q2 | $1.14M | Sell |
11,196
-15,079
| -57% | -$1.54M | ﹤0.01% | 2904 |
|
|
2023
Q1 | $4.64M | Sell |
26,275
-1,968
| -7% | -$348K | ﹤0.01% | 2505 |
|
|
2022
Q4 | $10.9K | Buy |
28,243
+61
| +0.2% | +$24 | ﹤0.01% | 2166 |
|
|
2022
Q3 | $9.5M | Sell |
28,182
-821
| -3% | -$277K | ﹤0.01% | 2177 |
|
|
2022
Q2 | $9.53M | Buy |
29,003
+6,998
| +32% | +$2.3M | ﹤0.01% | 2218 |
|
|
2022
Q1 | $9.63M | Buy |
22,005
+7,245
| +49% | +$3.17M | ﹤0.01% | 2311 |
|
|
2021
Q4 | $6.47M | Buy |
14,760
+4,924
| +50% | +$2.16M | ﹤0.01% | 2484 |
|
|
2021
Q3 | $5.47M | Sell |
9,836
-1,849
| -16% | -$1.03M | ﹤0.01% | 2555 |
|
|
2021
Q2 | $6M | Buy |
11,685
+9,925
| +564% | +$5.1M | ﹤0.01% | 2551 |
|
|
2021
Q1 | $1.37M | Sell |
1,760
-150
| -8% | -$117K | ﹤0.01% | 2940 |
|
|
2020
Q4 | $1.04M | Buy |
1,910
+48
| +3% | +$26.2K | ﹤0.01% | 2971 |
|
|
2020
Q3 | $853K | Buy |
1,862
+10
| +0.5% | +$4.58K | ﹤0.01% | 2965 |
|
|
2020
Q2 | $1.14M | Buy |
1,852
+901
| +95% | +$555K | ﹤0.01% | 2901 |
|
|
2020
Q1 | $452K | Hold |
951
| – | – | ﹤0.01% | 3072 |
|
|
2019
Q4 | $552K | Buy |
+951
| New | +$552K | ﹤0.01% | 3121 |
|
|
2018
Q2 | – | Sell |
-586
| Closed | -$261K | – | 3382 |
|
|
2018
Q1 | $261K | Hold |
586
| – | – | ﹤0.01% | 3193 |
|
|
2017
Q4 | $258K | Hold |
586
| – | – | ﹤0.01% | 3182 |
|
|
2017
Q3 | $289K | Sell |
586
-5,157
| -90% | -$2.54M | ﹤0.01% | 3172 |
|
|
2017
Q2 | $3.18M | Sell |
5,743
-33
| -0.6% | -$18.3K | ﹤0.01% | 2733 |
|
|
2017
Q1 | $3.82M | Sell |
5,776
-603
| -9% | -$399K | ﹤0.01% | 2653 |
|
|
2016
Q4 | $2.13M | Buy |
6,379
+1,737
| +37% | +$581K | ﹤0.01% | 2801 |
|
|
2016
Q3 | $1.4M | Buy |
+4,642
| New | +$1.4M | ﹤0.01% | 2863 |
|